|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/50 | |
| A61K 31/4015 |
| (11) | Patento numeris | 2358361 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09752825.1 |
| Europos patento paraiškos padavimo data | 2009-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/065270 |
| Data | 2009-11-17 |
| (87) | Numeris | WO 2010/057869 |
| Data | 2010-05-27 |
| (30) | Numeris | Data | Šalis |
| 08105817 | 2008-11-18 | EP | |
| 09100311 | 2009-06-02 | EP |
| (72) |
FANARA, Domenico, BE
EECKMAN, Frederic, BE
BERWAER, Monique, BE
|
| (73) |
UCB Biopharma SPRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | PROLONGED RELEASE FORMULATIONS COMPRISING AN 2-OXO-1-PYRROLIDINE DERIVATE |
| PROLONGED RELEASE FORMULATIONS COMPRISING AN 2-OXO-1-PYRROLIDINE DERIVATE |